Dispatch from CTAD 2024
Would you want to know if you were on the road to Alzheimer’s 20 years before you have any memory loss? My feeling is…
Would you want to know if you were on the road to Alzheimer’s 20 years before you have any memory loss? My feeling is…
In just a single year of studying a rare genetic mutation in a single family in the Arctic reaches of remote northern Sweden, a…
Driven by advances in new biomarker detection technologies and the approval of Leqembi — a disease-modifying therapy — scientists are updating the definition of…
At least nine different vaccines are currently in clinical trials for treating Alzheimer’s disease. While none of these vaccine candidates have started Phase 3…
At the 16th Annual Clinical Trials in Alzheimer’s Disease (CTAD) this week, T3D Therapeutics shared early data on an experimental Alzheimer’s pill they’re calling…
Hello from the CTAD Alzheimer’s research conference in San Francisco, where I am attending this year’s meeting on the latest announcements on Alzheimer’s disease…
A highly anticipated Alzheimer’s conference opened here last night with reports about a powerful new drug for treating dementia-related delusions and promising developments in…